Skip to content
Screener

Bausch Health Companies BHC Common Stock Shares Issued

Common Stock Shares Issued at other companies

Bausch + Lomb logo
Bausch + LombBLCO
357.1M+0.9%
Ardelyx logo
ArdelyxARDX
249.1M+3.5%
TTR
Turn Therapeutics Inc.TTRX
$29.79M
PBH
Prestige Consumer HealthcarePBH
56.3M+0.3%
HRO
HarrowHROW
37.5M+2.1%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
15M+0.2%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.37B+11.7%
Enterprise value$21.83B-1.3%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemMarch 31,2026December 31,2025
Total liabilities25,58025,989
Commitments and contingencies (Note 17)
(Deficit) Equity
Common shares, no par value, unlimited shares authorized, 373,464,760 and 370,531,987 issued and outstanding at March 31, 2026 and December 31, 2025, respectively10,54210,516
Additional paid-in capital295357
Accumulated deficit(11,090)(9,667)
Accumulated other comprehensive loss(1,806)(1,760)
Total Bausch Health Companies Inc. shareholders’ deficit(2,059)(554)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's common stock shares issued?
Bausch Health Companies (BHC) reported common stock shares issued of 373.5M in Q1 2026.
How has Bausch Health Companies's common stock shares issued changed year-over-year?
Bausch Health Companies's common stock shares issued increased by 1.1% year-over-year, from 369.5M to 373.5M.
What is the long-term trend for Bausch Health Companies's common stock shares issued?
Over 3 years (2022 to 2025), Bausch Health Companies's common stock shares issued has grown at a 0.8% compound annual growth rate (CAGR), from 361.9M to 370.5M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about Bausch Health Companies's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude